The present invention discloses a method of isolation, pooling and further culturing of Mesenchymal Stem cells (MSC) for clinical application. The present invention discloses the method of establishing a Master Cell Bank, followed by Working Cell Bank from which the final therapeutic composition referred to as Investigational product/Investigational Medicinal Product comprising of allogenic bone marrow-derived MSC is formulated for clinical applications.